Export Bureau manufacturing company directory
chinese japanese korean german spanish
Company Report
Nexgen Biotechnologies, Inc
popularity rank against competing companies
traffic rank against competing companies
total rank     traffic rank
Nexgen Biotechnologies Inc was established in November 1999 with the goal of conducting leading edge research in the area of Plant Biotechnology. Since its inception the company has been focused on advancing the next generation of biotechnology.
Country: Korea, South
City: Seoul
Address: 3F Simone Bldg. 144-1 Samsung-dong, Gangnam-gu,
Phone: 82234533090
Fax: 82234535251
Number of company employees : 10-50
Approximate annual sales : USD$2,500,000
Percentage of exports : 20%
Website: www.nexgenbiotech.com
Catagory:Beauty Sub-categories:  Cosmetics  Skin Products  Beauty Mixed
We can verify that Nexgen Biotechnologies, Inc has been registered with ExportBureau
from 23/08/2004 to today 18/03/2018 for a period of 13 years and 210 days.
Report this company
Nexgen Biotechnologies, Inc has received 31 contacts
Sending message...

Thank you ! We have sent your message.

 Send Secure Email Enquiry
Your name arrow

Your message will be sent to the receiver directly, unmodified including your direct return email address for them to contact. By using this contact form you come under ExportBureau fraud dispute protection and marketplace introduction.

Your company arrow
Your return email arrow
Your phone number arrow
Your country arrow
Your business arrow
Buyer Seller
Your enquiry arrow
Price  Specifications Sample cost
Minimum order quantity Delivery time Other
Your message arrow

max 3000 letters
enter codes  letterletterletter

USD Converted to
KRW Korean Won 1067.742

The mid-market rates shown here are neither "buy" rates nor "sell" rates. Mid-market rates are derived from mid-point between the buy and sell rates of large-value transactions in the global currency markets. Actual ExportBureau member rates are often better.

This report should be used only as a guide to build a more informed opinion on potential international trading partners.
click here to update this company information